article_metadata: Luke A Moradi Curtis A Clark Craig S Schneider Alok S Deshane Michael C Dobelbower
article_metadata: 10.3389/fimmu.2021.788499
article_metadata: Front Immunol
article_metadata: 2021 Dec 8;12:788499.
article_metadata: abscopal effect autoimmune myasthenia gravis immunotherapy case report metastatic melanoma radiation therapy
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34956219/
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Chemoradiotherapy / adverse effects Colitis / drug therapy Immune Checkpoint Inhibitors / therapeutic use Immunosuppressive Agents / therapeutic use Melanoma / therapy Myasthenia Gravis / drug therapy Prednisone / therapeutic use Skin Neoplasms / therapy
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Chemoradiotherapy / adverse effects Colitis / drug therapy Immune Checkpoint Inhibitors / therapeutic use Immunosuppressive Agents / therapeutic use Melanoma / therapy Myasthenia Gravis / drug therapy Prednisone / therapeutic use Skin Neoplasms / therapy Case Reports Review Aged Antibodies, Monoclonal, Humanized / adverse effects Colitis / chemically induced Colitis / diagnosis Colitis / immunology Humans Immune Checkpoint Inhibitors / adverse effects Immunocompromised Host Male Melanoma / immunology Melanoma / secondary Myasthenia Gravis / diagnosis Myasthenia Gravis / immunology Skin Neoplasms / immunology Skin Neoplasms / pathology Treatment Outcome Antibodies, Monoclonal, Humanized Immune Checkpoint Inhibitors Immunosuppressive Agents vedolizumab pembrolizumab Prednisone
article_metadata: PMC8692289
article_metadata: 34956219
article_metadata: Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis
article_metadata: 2021